Edoardo Cignoli : Bristol-Myers Revenue Improves

Bristol Myers reported a better-than-expected 6% rise in fourth-quarter revenue, benefiting from strong sales growth in its cancer drugs.



via WSJ.com: US Business http://ift.tt/1hr4ffi